MIR609

gene
On this page

Also known as hsa-mir-609

Summary

MIR609 (microRNA 609, HGNC:32865) is a microRNA gene on chromosome 10q25.1.

microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.

Source: NCBI Gene 693194 — RefSeq curated summary.

At a glance

  • Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:32865
Approved symbolMIR609
NamemicroRNA 609
Location10q25.1
Locus typeRNA, micro
StatusApproved
Aliaseshsa-mir-609
Ensembl geneENSG00000208033
Ensembl biotypemiRNA
Entrez693194
RNAcentralURS00006E8036 — miRNA, 95 nt, 3 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 miRNA

ENST00000385298

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000385298 — 1 exons

ExonStartEnd
ENSE00001500304104218789104218883

Expression profiles

Bgee: expression breadth broad, 49 present calls, max score 80.62.

Top tissues by expression

49 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
olfactory segment of nasal mucosaUBERON:000538680.62gold quality
transverse colonUBERON:000115775.24gold quality
monocyteCL:000057674.98gold quality
body of pancreasUBERON:000115074.52gold quality
bloodUBERON:000017873.01gold quality
kidneyUBERON:000211372.93gold quality
right adrenal glandUBERON:000123372.61gold quality
lungUBERON:000204871.61gold quality
body of stomachUBERON:000116171.52gold quality
subcutaneous adipose tissueUBERON:000219070.98gold quality
endometriumUBERON:000129570.77gold quality
right uterine tubeUBERON:000130270.51gold quality
right atrium auricular regionUBERON:000663170.43gold quality
right lobe of liverUBERON:000111469.72gold quality
esophagogastric junction muscularis propriaUBERON:003584169.31gold quality
left uterine tubeUBERON:000130368.23gold quality
omental fat padUBERON:001041467.56gold quality
muscle layer of sigmoid colonUBERON:003580566.78gold quality
amygdalaUBERON:000187666.74gold quality
skin of legUBERON:000151166.52gold quality
Ammon’s hornUBERON:000195466.48gold quality
skin of abdomenUBERON:000141665.95gold quality
right frontal lobeUBERON:000281065.37gold quality
minor salivary glandUBERON:000183065.29gold quality
lower esophagus muscularis layerUBERON:003583364.76gold quality
hypothalamusUBERON:000189864.67gold quality
caudate nucleusUBERON:000187364.01gold quality
small intestine Peyer’s patchUBERON:000345463.06gold quality
left ovaryUBERON:000211962.97gold quality
myometriumUBERON:000129662.87gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.98

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 1)

  • increased level of serum miR-609 in patients with thalassemia is a risk factor for poor prognosis and can be used as a reference index for evaluating the efficacy for patients (PMID:31839062)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.